Clinipace Worldwide


Caidya is a global, full-service Contract Research Organization (CRO) dedicated to transforming clinical research through personalized, innovative, and flexible solutions. With over 20 years of experience, they partner with biopharma innovators to bring life-changing therapies to patients worldwide, emphasizing agility, expertise, and a patient-centric approach. Caidya is committed to transparency, data sharing, and fostering an inclusive culture, with a focus on delivering superior customer experiences and advancing healthcare through clinical trials.

Industries

biotechnology
clinical-trials
medical
mhealth
therapeutics

Nr. of Employees

Very Large (1000+)

Clinipace Worldwide

Morrisville, North Carolina, United States, North America


Services

End-to-end clinical development support covering early-phase through later-phase studies including protocol development, operations, safety and program management.

Operational services including study start-up, site activation, patient pathway design, feasibility assessments and investigator network utilization to accelerate recruitment and activation.

Regulatory strategy, submissions support, medical writing and pharmacovigilance to maintain compliance and safety oversight across clinical programs.

Biometrics, biostatistics, clinical data management, clinical analytics, RBQM and clinical technology ecosystem services including AI governance and eClinical system integration.

Integration of trial data streams into a consolidated, near-real-time view to support oversight, reporting and decision-making across the study lifecycle.

Design and operational execution of decentralized and hybrid trial models using remote assessments, telemedicine and logistics to reduce participant burden and increase access.

View All Services

Expertise Areas

  • Clinical trial management
  • Early-phase development
  • Phase II/III trial execution
  • Biostatistics and biometrics
  • Show More (12)

Key Technologies

  • Electronic Data Capture (EDC)
  • Interactive Response Technology (IRT)
  • Clinical Trial Management System (CTMS)
  • Electronic Trial Master File (eTMF)
  • Show More (9)

News & Updates

Caidya’s John Wang was named Chair of the China CDISC Coordinating Committee, highlighting leadership in data management.

Caidya announced Adam Callahan as Head of Oncology and Hematology to bolster therapeutic expertise.

Brandon Pallott was named Chief Commercial Officer to lead commercial growth and market expansion.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.